A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Incyte Corporation
Actym Therapeutics, Inc.
Turnstone Biologics, Corp.
Taiho Oncology, Inc.
Sotio Biotech Inc.
Deciphera Pharmaceuticals, LLC
Molecular Templates, Inc.
Pfizer
Kyowa Kirin Co., Ltd.
Verastem, Inc.
Bayer
MacroGenics
Incyte Corporation
Boehringer Ingelheim
Sanofi
Pierian Biosciences
Precision Therapeutics
Anza Therapeutics, Inc.